Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215902
Company: AUROBINDO PHARMA
Company: AUROBINDO PHARMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SAFINAMIDE MESYLATE | SAFINAMIDE MESYLATE | EQ 50MG BASE | TABLET;ORAL | Discontinued | None | No | No |
| SAFINAMIDE MESYLATE | SAFINAMIDE MESYLATE | EQ 100MG BASE | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/14/2023 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215902Orig1s000ltr.pdf |